SCHEMBL4159402

SCHEMBL4159402

CCOC(=O)c1cc(C2=C(c3cccnc3OC)CCC2)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.43
GRM7 Q14831 1/20 0.39
TGFBR1 P36897 1/20 0.39
L3MBTL1 Q9Y468 5/20 0.38
ATM Q13315 2/20 0.38
MAPT P10636 2/20 0.38
ALDH1A1 P00352 2/20 0.38
KMT2A Q03164 1/20 0.38
DHODH Q02127 1/20 0.38
NPC1 O15118 3/20 0.37
RAB9A P51151 2/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
NAAA Q02083 1/20 0.37
ALOX5AP P20292 1/20 0.37
FEN1 P39748 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13697402 0.90 FFAR4 (0.41) FFAR4TGFBR1L3MBTL1ATMMAPT
SCHEMBL4155978 0.88 L3MBTL1 (0.46) L3MBTL1MAPTKMT2ARAB9ACASP3
SCHEMBL4159104 0.85 GRM7 (0.40) GRM7ATMMAPTALDH1A1KMT2A
SCHEMBL4150747 0.80 PTGER1 (0.45) L3MBTL1MAPTALDH1A1MAPK1SMN1; SMN2
SCHEMBL16060393 0.79 ACHE (0.41) L3MBTL1MAPTALDH1A1SMN1; SMN2
SCHEMBL13696910 0.79 PTGER1 (0.52) L3MBTL1ATMMAPTALDH1A1KMT2A
SCHEMBL13697486 0.78 MCL1 (0.46) FFAR4DHODH
SCHEMBL13696740 0.77 CYP2C9 (0.43) ATMMAPTALDH1A1KMT2ANPC1
SCHEMBL13697417 0.76 CYP2C9 (0.41) ATMNPC1RAB9ACASP3SENP8
SCHEMBL4163577 0.75 PTGER1 (0.48) MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227591-A1 Cyclopentene compounds GLAXO GROUP LIMITED (GB) 2009-09-10 US disclosed
US-20090227591-A1 Cyclopentene compounds GLAXO GROUP LIMITED (GB) 2009-09-10 US disclosed
US-20090227591-A1 Cyclopentene compounds GLAXO GROUP LIMITED (GB) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227591-A1 Cyclopentene compounds C1R, CYP1B1, ADORA2B FFAR4 2668/4885GRM7 3587/4885TGFBR1 568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.